Indication
Multifocal Motor Neuropathy
3 clinical trials
2 products
Clinical trial
A Phase 3 Study to Evaluate the Efficacy, Safety and Tolerability of TAK-771 for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN) in Japanese SubjectsStatus: Active (not recruiting), Estimated PCD: 2024-03-05
Product
TAK-771Clinical trial
A Long-term Extension of the ARGX-117-2002 Trial to Evaluate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor NeuropathyStatus: Recruiting, Estimated PCD: 2025-11-01
Product
ARGX-117Clinical trial
A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor NeuropathyStatus: Active (not recruiting), Estimated PCD: 2024-10-01